Search research articles
Contact Us
Filters
Showing results (491-500 of 554) with videos related to
Page
of 56
Sort By:
Journal for Immunotherapy of Cancer
|
March 22, 2023
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)
Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2024
Safety of pembrolizumab as adjuvant therapy in a pooled analysis of phase 3 clinical trials of melanoma, non-small cell lung cancer, and renal cell carcinoma
Jason J Luke, Georgina V Long, Caroline Robert, et al.
Kidney Cancer (Clifton, Va.)
|
October 19, 2018
Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path Forward
L C Harshman, C G Drake, N B Haas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2022
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A)
Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, et al.
Cancer Research Communications
|
February 22, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid Tumors
Jong Chul Park, David Berz, Manish R Sharma, et al.
BMC Medical Genomics
|
March 11, 2025
A genome-wide association study of methamphetamine use among people with HIV
A Venkataraman, T Jia, S A Ruderman, et al.
JACC. Cardiooncology
|
July 10, 2024
Social Determinants of Health Mediate Racial Disparities in Cardiovascular Disease in Men With Prostate Cancer
Biniyam G Demissei, Kyunga Ko, Anran Huang, et al.
European Urology Oncology
|
November 5, 2023
Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer
John K Lin, Caleb M Hearn, Emily Getzen, et al.
The Lancet. Oncology
|
September 2, 2022
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Thomas Powles, Piotr Tomczak, Se Hoon Park, et al.
Science Translational Medicine
|
November 9, 2022
BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion
In-Young Jung, Vivek Narayan, Sierra McDonald, et al.
Page
of 56
Search research articles
Search
Showing results (491-500 of 554) with videos related to
Sort By:
Page
of 56
Journal for Immunotherapy of Cancer
|
March 22, 2023
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)
Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2024
Safety of pembrolizumab as adjuvant therapy in a pooled analysis of phase 3 clinical trials of melanoma, non-small cell lung cancer, and renal cell carcinoma
Jason J Luke, Georgina V Long, Caroline Robert, et al.
Kidney Cancer (Clifton, Va.)
|
October 19, 2018
Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path Forward
L C Harshman, C G Drake, N B Haas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2022
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A)
Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, et al.
Cancer Research Communications
|
February 22, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid Tumors
Jong Chul Park, David Berz, Manish R Sharma, et al.
BMC Medical Genomics
|
March 11, 2025
A genome-wide association study of methamphetamine use among people with HIV
A Venkataraman, T Jia, S A Ruderman, et al.
JACC. Cardiooncology
|
July 10, 2024
Social Determinants of Health Mediate Racial Disparities in Cardiovascular Disease in Men With Prostate Cancer
Biniyam G Demissei, Kyunga Ko, Anran Huang, et al.
European Urology Oncology
|
November 5, 2023
Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer
John K Lin, Caleb M Hearn, Emily Getzen, et al.
The Lancet. Oncology
|
September 2, 2022
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Thomas Powles, Piotr Tomczak, Se Hoon Park, et al.
Science Translational Medicine
|
November 9, 2022
BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion
In-Young Jung, Vivek Narayan, Sierra McDonald, et al.
Page
of 56